--- title: "DoBe Group released its performance for the first half of the year, with a net profit attributable to the parent company of 7.9753 million yuan, a decrease of 41.15%" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/254972682.md" description: "According to the Zhitong Finance APP, DoBe Group released its semi-annual report for 2025, showing an operating income of 602 million yuan, a year-on-year decrease of 4.56%. The net profit attributable to shareholders of the listed company was 7.9753 million yuan, a year-on-year decrease of 41.15%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 2.963 million yuan. The basic earnings per share were 0.05 yuan" datetime: "2025-08-28T10:02:59.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/254972682.md) - [en](https://longbridge.com/en/news/254972682.md) - [zh-HK](https://longbridge.com/zh-HK/news/254972682.md) --- > 支持的语言: [English](https://longbridge.com/en/news/254972682.md) | [繁體中文](https://longbridge.com/zh-HK/news/254972682.md) # DoBe Group released its performance for the first half of the year, with a net profit attributable to the parent company of 7.9753 million yuan, a decrease of 41.15% According to the Zhitong Finance APP, DoBe Group (300947.SZ) released its semi-annual report for 2025, showing an operating income of 602 million yuan, a year-on-year decrease of 4.56%. The net profit attributable to shareholders of the listed company was 7.9753 million yuan, a year-on-year decrease of 41.15%. The net loss attributable to shareholders of the listed company, after deducting non-recurring gains and losses, was 2.963 million yuan. The basic earnings per share were 0.05 yuan ### 相关股票 - [DoBe Group (300947.CN)](https://longbridge.com/zh-CN/quote/300947.CN.md) ## 相关资讯与研究 - [CATL's controlling shareholder to donate some A-shares](https://longbridge.com/zh-CN/news/281197776.md) - [GARO AB Calls 2026 AGM, Sets Agenda on Governance, Capital Moves and CEO Incentives](https://longbridge.com/zh-CN/news/281495021.md) - [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/zh-CN/news/281325910.md) - [Midea Unveils the H-Pack at MCE 2026: A Major Step Forward in Affordable Compact Heat Pump Technology and Service](https://longbridge.com/zh-CN/news/281210504.md) - [04:37 ETMidea Launches V9 VRF: Redefining Efficiency, Reliability and Easy Installation in Commercial HVAC](https://longbridge.com/zh-CN/news/280981925.md)